BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31160751)

  • 1. Low-level mosaicism in tuberous sclerosis complex: prevalence, clinical features, and risk of disease transmission.
    Giannikou K; Lasseter KD; Grevelink JM; Tyburczy ME; Dies KA; Zhu Z; Hamieh L; Wollison BM; Thorner AR; Ruoss SJ; Thiele EA; Sahin M; Kwiatkowski DJ
    Genet Med; 2019 Nov; 21(11):2639-2643. PubMed ID: 31160751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genetic and phenotype analysis of 95 individuals with mosaic tuberous sclerosis complex.
    Klonowska K; Giannikou K; Grevelink JM; Boeszoermenyi B; Thorner AR; Herbert ZT; Afrin A; Treichel AM; Hamieh L; Kotulska K; Jozwiak S; Moss J; Darling TN; Kwiatkowski DJ
    Am J Hum Genet; 2023 Jun; 110(6):979-988. PubMed ID: 37141891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic distinctions between mosaic forms of tuberous sclerosis complex.
    Treichel AM; Hamieh L; Nathan NR; Tyburczy ME; Wang JA; Oyerinde O; Raiciulescu S; Julien-Williams P; Jones AM; Gopalakrishnan V; Moss J; Kwiatkowski DJ; Darling TN
    Genet Med; 2019 Nov; 21(11):2594-2604. PubMed ID: 31114024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of TSC1/TSC2 mosaic variants in patients with cardiac rhabdomyoma and tuberous sclerosis complex by hybrid-capture next-generation sequencing.
    Wang S; Sun H; Wang J; Gu X; Han L; Wu Y; Yan H; Han L; Zhang H; He Y
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1802. PubMed ID: 34480426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TSC2 pathogenic variants are predictive of severe clinical manifestations in TSC infants: results of the EPISTOP study.
    Ogórek B; Hamieh L; Hulshof HM; Lasseter K; Klonowska K; Kuijf H; Moavero R; Hertzberg C; Weschke B; Riney K; Feucht M; Scholl T; Krsek P; Nabbout R; Jansen AC; Benova B; Aronica E; Lagae L; Curatolo P; Borkowska J; Sadowski K; Domańska-Pakieła D; Janson S; Kozlowski P; Urbanska M; Jaworski J; Jozwiak S; Jansen FE; Kotulska K; ; Kwiatkowski DJ
    Genet Med; 2020 Sep; 22(9):1489-1497. PubMed ID: 32461669
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-level mosaicism in tuberous sclerosis complex in four unrelated patients: Comparison of clinical characteristics and diagnostic pathways.
    Manzanilla-Romero HH; Weis D; Schnaiter S; Rudnik-Schöneborn S
    Am J Med Genet A; 2021 Dec; 185(12):3851-3858. PubMed ID: 34328706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mosaicism in tuberous sclerosis complex: Lowering the threshold for clinical reporting.
    Ye Z; Lin S; Zhao X; Bennett MF; Brown NJ; Wallis M; Gao X; Sun L; Wu J; Vedururu R; Witkowski T; Gardiner F; Stutterd C; Duan J; Mullen SA; McGillivray G; Bodek S; Valente G; Reagan M; Yao Y; Li L; Chen L; Boys A; Adikari TN; Cao D; Hu Z; Beshay V; Zhang VW; Berkovic SF; Scheffer IE; Liao J; Hildebrand MS
    Hum Mutat; 2022 Dec; 43(12):1956-1969. PubMed ID: 36030538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs.
    Dabora SL; Jozwiak S; Franz DN; Roberts PS; Nieto A; Chung J; Choy YS; Reeve MP; Thiele E; Egelhoff JC; Kasprzyk-Obara J; Domanska-Pakiela D; Kwiatkowski DJ
    Am J Hum Genet; 2001 Jan; 68(1):64-80. PubMed ID: 11112665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genotype/phenotype correlation in 123 Chinese patients with Tuberous Sclerosis Complex.
    Ng SY; Luk HM; Hau EW; Cheng SS; Yu KP; Ho S; Mok MT; Lo IF
    Eur J Med Genet; 2022 Oct; 65(10):104573. PubMed ID: 35918040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex.
    Qin W; Kozlowski P; Taillon BE; Bouffard P; Holmes AJ; Janne P; Camposano S; Thiele E; Franz D; Kwiatkowski DJ
    Hum Genet; 2010 Mar; 127(5):573-82. PubMed ID: 20165957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of neurodevelopmental abnormalities, congenital heart and renal defects in a tuberous sclerosis complex patient cohort.
    Robinson J; Uzun O; Loh NR; Harris IR; Woolley TE; Harwood AJ; Gardner JF; Syed YA
    BMC Med; 2022 Apr; 20(1):123. PubMed ID: 35440050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genotype and Phenotype Landscape of 283 Japanese Patients with Tuberous Sclerosis Complex.
    Togi S; Ura H; Hatanaka H; Niida Y
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of a patient with tuberous sclerosis complex due to mosaicism TSC2 mutation].
    Liu W; Li F; He Z; Ai R
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Jan; 39(1):68-71. PubMed ID: 34964971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutational analysis of TSC1 and TSC2 in Danish patients with tuberous sclerosis complex.
    Rosengren T; Nanhoe S; de Almeida LGD; Schönewolf-Greulich B; Larsen LJ; Hey CAB; Dunø M; Ek J; Risom L; Nellist M; Møller LB
    Sci Rep; 2020 Jun; 10(1):9909. PubMed ID: 32555378
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First comprehensive TSC1/TSC2 mutational analysis in Mexican patients with Tuberous Sclerosis Complex reveals numerous novel pathogenic variants.
    Reyna-Fabián ME; Hernández-Martínez NL; Alcántara-Ortigoza MA; Ayala-Sumuano JT; Enríquez-Flores S; Velázquez-Aragón JA; Varela-Echavarría A; Todd-Quiñones CG; González-Del Angel A
    Sci Rep; 2020 Apr; 10(1):6589. PubMed ID: 32313033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1/TSC2 genes.
    Lin S; Zeng JB; Zhao GX; Yang ZZ; Huang HP; Lin MT; Wu ZY; Wang N; Chen WJ; Fang L
    Seizure; 2019 Oct; 71():322-327. PubMed ID: 31525612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetics, genomics, and genotype-phenotype correlations of TSC: Insights for clinical practice.
    Peron A; Au KS; Northrup H
    Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):281-290. PubMed ID: 30255984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sporadic facial angiofibroma and sporadic angiomyolipoma mimicking tuberous sclerosis complex.
    Klonowska K; Thiele EA; Grevelink JM; Thorner AR; Kwiatkowski DJ
    J Med Genet; 2022 Sep; 59(9):920-923. PubMed ID: 34635572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Integral Approach to the Molecular Diagnosis of Tuberous Sclerosis Complex: The Role of Mosaicism and Splicing Variants.
    Blasco-Pérez L; Iranzo-Nuez L; López-Ortega R; Martínez-Cruz D; Camprodon-Gómez M; Tenés A; Antolín M; Tizzano EF; García-Arumí E
    J Mol Diagn; 2023 Sep; 25(9):692-701. PubMed ID: 37356622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Minimal mosaicism, maximal phenotype: Discordance between clinical and molecular findings in two patients with tuberous sclerosis.
    Byers HM; Jensen DM; Glass IA; Bennett JT
    Am J Med Genet C Semin Med Genet; 2018 Sep; 178(3):374-378. PubMed ID: 30260069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.